Loading…
TriSalus Life Sciences, Inc. is projected to rise to $4.74 by 2027, a +14% move from its current price of $4.14. TLSI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $3.95 | $4.14 | $4.34 | -0.01% |
| Jul 14 | $3.87 | $4.14 | $4.42 | -0.03% |
| Jul 15 | $3.81 | $4.14 | $4.49 | -0.04% |
| Jul 16 | $3.77 | $4.14 | $4.55 | -0.06% |
| Jul 17 | $3.72 | $4.14 | $4.60 | -0.07% |
| Jul 18 | $3.68 | $4.14 | $4.64 | -0.09% |
| Jul 19 | $3.65 | $4.14 | $4.69 | -0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.65 | $4.14 | $4.69 | -0.10% |
| Week 2 | $3.46 | $4.13 | $4.93 | -0.21% |
| Week 3 | $3.32 | $4.13 | $5.12 | -0.31% |
| Week 4 | $3.21 | $4.12 | $5.29 | -0.42% |
| Week 5 | $3.12 | $4.12 | $5.44 | -0.52% |
| Week 6 | $3.03 | $4.11 | $5.59 | -0.63% |
| Week 7 | $2.95 | $4.11 | $5.72 | -0.73% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
TriSalus Life Sciences, Inc. is a Healthcare company focused on the research, development, and commercialization of a drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer.
The company was founded in 2009 and is headquartered in Westminster, Colorado. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, and value analysis committee staff.
TLSI is currently priced at $4.14 and has a market capitalization of $254.26M. It ranks 3617 among assets. The 30-day technical picture shows a bullish tilt with RSI(14) at 50, SMA(50) of $3.84 and SMA(200) of $4.81, with a support at $3.17 and resistance at $4.74. The 30-day price range spans $3.03 to $5.65.
From a multi-year perspective, the forecast projects meaningful upside: the average price is $4.14 in 2026, rising to $9.58 in 2030 and $40.93 by 2050, with maximums up to $94.15. Notable return figures include an ROI of 131.5% in 2030, 396% by 2040, and 888.8% by 2050, with sentiment remaining BULLISH across the longer horizon.
A major floor 40.9% below — a decisive break under it would weaken the trend.
The nearest floor, 23.4% below — buyers have tended to step in here.
The nearest ceiling, 14.5% above — a clean break opens room to run.
A major ceiling 34.9% above — clearing it would confirm fresh momentum.
Key TLSI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TLSI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.02 | Buy | $4.08 | Buy |
| MA 10 | $4.33 | Sell | $4.15 | Sell |
| MA 20 | $4.19 | Sell | $4.10 | Buy |
| MA 50 | $3.84 | Buy | $4.02 | Buy |
| MA 100 | $4.14 | Buy | $4.22 | Sell |
| MA 200 | $4.81 | Sell | $4.55 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.63 | Neutral |
| Stoch RSI (14) | 35.13 | Neutral |
| CCI (20) | -12.51 | Neutral |
| Williams %R (14) | -56.60 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | 2.73 | Buy |
| Bollinger %B (20,2) | 0.46 | Neutral |
| Stochastic %K (14) | 43.40 | Neutral |
| TRIX (15) | 0.66 | Buy |
| Awesome (5,34) | 0.19 | Buy |
| Ultimate (7,14,28) | 44.69 | Neutral |
| Momentum (10) | -0.23 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 3.74 | Buy |
| ADX (14) | 16.08 | Neutral |
| ATR (14) | 0.21 | Info |
The 30-day technical picture is bullish. RSI(14) is 50, and the asset trades near the middle of its range with a SMA50 of $3.84 and a SMA200 of $4.81. Immediate support is noted at $3.17 and resistance at $4.74. The 30-day price range runs from $3.03 to $5.65, indicating recent volatility within a defined band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.52 | $4.14 | $5.04 | 0% | Neutral | |
| $3.52 | $4.74 | $6.88 | +14% | Neutral | |
| $4.24 | $6.02 | $9.26 | +45% | Bullish | |
| $5.32 | $7.89 | $12.69 | +91% | Bullish | |
| $6.21 | $9.58 | $15.99 | +131% | Bullish | |
| $5.47 | $8.77 | $15.11 | +112% | Bullish | |
| $5.60 | $9.30 | $16.48 | +125% | Bullish | |
| $6.35 | $10.90 | $19.80 | +163% | Bullish | |
| $6.51 | $11.54 | $21.46 | +179% | Bullish | |
| $8.57 | $15.69 | $29.80 | +279% | Bullish | |
| $9.66 | $20.55 | $42.64 | +396% | Bullish | |
| $18.41 | $40.90 | $94.07 | +888% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.52 | $4.14 | $4.96 | +0.00% |
| August 2026 | $3.27 | $3.94 | $4.92 | -4.86% |
| September 2026 | $3.35 | $4.08 | $5.20 | +3.68% |
| October 2026 | $3.41 | $4.20 | $5.43 | +2.78% |
| November 2026 | $3.18 | $3.95 | $5.18 | -5.85% |
| December 2026 | $3.03 | $3.80 | $5.04 | -3.86% |
Click any year to see its month-by-month TLSI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
TriSalus Life Sciences, Inc.'s 2026 outlook centres on $4.14, within a $2.52 to $5.04 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, TLSI could reach as high as $6.88, with a base case around $4.74 and support toward $3.52 — roughly +14% from $4.14. Price action looks broadly range-bound.
Expect TLSI to range from $4.24 to $9.26 through 2028. The $6.02 average target implies a +45% move from current prices. That is up +27% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The TLSI price prediction for 2029 points to an average of $7.89 (low $5.32, high $12.69) — a potential gain of +91% on today's $4.14. Momentum favours further upside here.
In 2030, TLSI is projected to trade between $6.21 and $15.99, averaging $9.58 — a potential gain of +131% from today's $4.14. That is up +21% on the projected 2029 average. Buyers look set to stay in control over this stretch.
TriSalus Life Sciences, Inc.'s 2031 outlook centres on $8.77, within a $5.47 to $15.11 range. That is -8% versus the projected 2030 average. That marks a +112% change versus current levels. Momentum favours further upside here.
By 2032, TLSI could reach as high as $16.48, with a base case around $9.30 and support toward $5.60 — roughly +125% from $4.14. Buyers look set to stay in control over this stretch.
Expect TLSI to range from $6.35 to $19.80 through 2033. The $10.90 average target implies a +163% move from current prices. That is up +17% on the projected 2032 average. Momentum favours further upside here.
The TLSI price prediction for 2034 points to an average of $11.54 (low $6.51, high $21.46) — a potential gain of +179% on today's $4.14. Buyers look set to stay in control over this stretch.
In 2035, TLSI is projected to trade between $8.57 and $29.80, averaging $15.69 — a potential gain of +279% from today's $4.14. That is up +36% on the projected 2034 average. Momentum favours further upside here.
TriSalus Life Sciences, Inc.'s 2040 outlook centres on $20.55, within a $9.66 to $42.64 range. That is up +31% on the projected 2035 average. That marks a +396% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, TLSI could reach as high as $94.07, with a base case around $40.90 and support toward $18.41 — roughly +888% from $4.14. Momentum favours further upside here.
Investing $1,000 in TLSI today (≈ 241.545894 TLSI) could be worth
$9,879.63
+$8,879.63 (+888%) by 2050 · US Dollar
Based on the average projected TLSI price of $40.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TLSIwould be worth at today's price.
$1,000 invested in TLSI on Jul 10, 2025 (≈ 200 TLSI) would be worth
$828
-$172 (-17.2%) today · 0.83× · US Dollar
Based on a TLSI entry price of $5 vs. today's $4.14.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.69 | $882.73 | -11.7% |
| 1 month ago | $3.55 | $1,166.2 | +16.6% |
| 3 months ago | $4.22 | $981.04 | -1.9% |
| 6 months ago | $5.87 | $705.28 | -29.5% |
| 1 year ago | $5 | $828 | -17.2% |
| All time (5.0y) ago | $9.75 | $424.62 | -57.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TLSI forecast.
Our base-case forecast reaches $8.30 around 2030.
Implied market cap at $8.30: $509.76M
The multi-year forecast shows a strong upside trajectory. The average price is projected to rise from $4.14 in 2026 to $9.58 in 2030 and to $40.93 by 2050, with max values up to $94.15. Key year-by-year markers include 2027 average of $4.74 (ROI 14.6%), 2028 average $6.02 (ROI 45.4%), 2029 average $7.90 (ROI 90.8%), and 2030 average $9.58 (ROI 131.5%).
By 2040, the average is $20.53 (ROI 396%), and by 2050 the average is $40.93 (ROI 888.8%). The outlook shifts to bullish momentum from the later years, with continued upside potential albeit with the usual uncertainty inherent in long-range forecasts. These figures are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $9.58 with a minimum of $6.21 and a maximum of $15.99, and an ROI of 131.5% with bullish sentiment.
The forecast shows positive upside in multiple years (e.g., 2027 avg $4.74, 2028 avg $6.02, 2029 avg $7.90, 2030 avg $9.58) with bullish sentiment beginning in 2028 and extending through 2050, though these are estimates and not guarantees.
Yes. The 2050 maximum is $94.15, which exceeds $50, indicating potential for higher-magnitude upside.
Current price is $4.14 and market capitalization is $254.26M, with a rank of 3617.
The 30-day range is $3.03 to $5.65.
TriSalus Life Sciences, Inc. Community Discussion
0Share your TriSalus Life Sciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.